跳至主要内容
临床试验/CTRI/2026/03/105539
CTRI/2026/03/105539尚未招募不适用

A non – randomized control trial to study the effect of twenty percent calorie restriction vs metformin in elderly individuals above 65 years , with early diabetes.

All india institute of medical sciences NEW DELHI1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年3月21日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
change in Hba1c levels

研究概览

简要总结

a non randomized control trial to compare metformin with 20% calorie restriction , in elderly individuals > = 65yr , MNA SF score > 10

primary outcome to compare change in HbA1c level after three months

secondary outcome to compare change in HOMA - IR score and quality of life assessment

patient excluded if already taking any other anti diabetic drug , on drug that modify glucose metabolism like steroid

if any of the exclusion for metformin met , advanced kidney and renal disease, allergy to metformin or gastrointestinal side effects present to metformin then participants are added to calorie restriction group

2 weekly telephonic calls to confirm adherence to treatment or development of complications

100 sample size , 50 for metformin group and 50 for calorie restriction group

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
60.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • recruiting elderly above age of 60yr.

排除标准

  • Severe cognitive impairement Taking drugs interfering with glucose metabolism ( eg steroids Exclusion for metformin group : Patient with end stage renal disease (stage 4 , 5 Chronic liver disease (Child pugh B,C ) Allergy to metformin Severe gastrointestinal side effects to metformin.

结局指标

主要结局

change in Hba1c levels

时间窗: baseline , 13weeks

次要结局

  • CHANGE IN HOMA -IR SCORE(CHANGE IN SF -36 SCORE)

研究者

发起方
All india institute of medical sciences NEW DELHI
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

dr kirti kamwani

AIIMS NEW DELHI

研究点 (1)

Loading locations...

相似试验